MIH
ALXN

Madison Investment Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

Madison Investment Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$290K Buy
2,965
+1,000
+51% +$113K ﹤0.01% 277
2019
Q2 		$257K Buy
+1,965
New +$253K ﹤0.01% 215

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Madison Investment Holdings's ALXN Position: Q3 2019 in Review

Madison Investment Holdings increased its Alexion Pharmaceuticals (ALXN) stake by 51% in Q3 2019, buying an estimated $113K and bringing the position to 2,965 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #277.

Madison Investment Holdings first reported a position in ALXN in Q2 2019 and has held it in 2 quarters since. 648 funds tracked by Wall St. Rank hold ALXN as of Q3 2019.

  • Madison Investment Holdings held 2,965 shares of Alexion Pharmaceuticals worth $290K as of Q3 2019.
  • Madison Investment Holdings bought 1,000 Alexion Pharmaceuticals shares in Q3 2019, an estimated $113K.
  • Alexion Pharmaceuticals made up ﹤0.01% of Madison Investment Holdings's portfolio in Q3 2019, its #277 holding.
  • Madison Investment Holdings first reported a position in Alexion Pharmaceuticals in Q2 2019 and has held it in 2 quarters since.
  • 648 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2019.

Based on Madison Investment Holdings's 13F filing for Q3 2019, filed 13 Nov 2019.